HROW
Harrow, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
38.87
close · 2026-08-13
value
16
cheaper than peers16
quality
2
stronger fundamentals2
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 14.34× | 46 |
| EV to EBITDA | 44.04× | 25 |
| price to sales | 5.65× | 21 |
| price to book | 50.48× | 12 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | -7.6% | 20 |
| return on equity | -35.4% | 20 |
| debt to equity | 1060.5% | 9 |
| operating margin | -50.0% | 4 |
4 of 4 measures available
Facts
| market cap | $1B |
| free cash flow | -$5.0M |
| employees | 373 |
| first trade | 2007-09-28 |
| next earnings | 2026-08-10 |
| fundamentals updated | 2026-08-10 |